Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 2003, p. 208-215, Vol. 10, No. 2
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.2.208-215.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Veterinary Microbiology and Pathology,1 Department of Veterinary Clinical Sciences, Washington State University,2 USDA Agricultural Research Service Animal Disease Research Unit, Pullman, Washington 99164-70403
Received 29 July 2002/ Accepted 24 October 2002
Rhodococcus equi is a gram-positive bacterium that infects alveolar macrophages and causes rhodococcal pneumonia in horses and humans. The virulence plasmid of R. equi appears to be required for both pathogenicity in the horse and the induction of protective immunity. An understanding of the mechanisms by which virulent R. equi circumvents protective host responses and by which bacteria are ultimately cleared is important for development of an effective vaccine. Six adult horses were challenged with either virulent R. equi or an avirulent, plasmid-cured derivative. By using a flow cytometric method for intracytoplasmic detection of gamma interferon (IFN-
) in equine bronchoalveolar lavage fluid (BALF) cells, clearance of the virulent strain was shown to be associated with increased numbers of pulmonary CD4+ and CD8+ T lymphocytes producing IFN-
. There was no change in IFN-
-positive cells in peripheral blood, suggesting that a type 1 recall response at the site of challenge was protective. The plasmid-cured strain of R. equi was cleared in horses without a significant increase in IFN-
-producing T lymphocytes in BALF. In contrast to these data, a previous report in foals suggested an immunomodulating role for R. equi virulence plasmid-encoded products in downregulating IFN-
expression by equine CD4+ T lymphocytes. Intracytoplasmic detection of IFN-
provides a method to better determine whether modulation of macrophage-activating cytokines by virulent strains occurs uniquely in neonates and contributes to their susceptibility to rhodococcal pneumonia.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |